Aliases & Classifications for Retinitis

MalaCards integrated aliases for Retinitis:

Name: Retinitis 12 51 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:3612
ICD10 32 H30.9
MeSH 41 D012173
NCIt 46 C115993
UMLS 69 C0035333

Summaries for Retinitis

MalaCards based summary : Retinitis is related to retinitis pigmentosa 2 and retinitis pigmentosa 6. An important gene associated with Retinitis is RPGR (Retinitis Pigmentosa GTPase Regulator), and among its related pathways/superpathways are Development_Thrombopoetin signaling via JAK-STAT pathway and the visual cycle I (vertebrates). The drugs Cidofovir and Ganciclovir have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and retina, and related phenotypes are Increased HPV16-GFP infection and pigmentation

Related Diseases for Retinitis

Diseases related to Retinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1568)
# Related Disease Score Top Affiliating Genes
1 retinitis pigmentosa 2 33.7 RP2 RPGR
2 retinitis pigmentosa 6 33.7 RHO RP9
3 retinitis pigmentosa 44 33.6 RGR RPGR
4 retinitis pigmentosa 9 33.6 IMPDH1 RP9
5 retinitis pigmentosa 7 33.6 PRPH2 RHO RP9
6 retinitis pigmentosa 10 33.4 IMPDH1 RHO RP9
7 peripheral retinal degeneration 33.4 PRPH2 RPGR
8 retinitis pigmentosa 1 33.3 IMPDH1 PRPH2 RHO RP1
9 retinitis pigmentosa 29 33.2 PRPF3 RGR
10 retinitis pigmentosa 18 33.0 IMPDH1 PRPF3 RP9
11 fundus albipunctatus 32.9 PRPH2 RHO RLBP1 RPE65
12 retinal disease 32.9 PRPH2 RHO RLBP1 RPE65 RPGR RPGRIP1
13 retinitis pigmentosa 13 32.8 IMPDH1 PRPF3 RP9 RPGR
14 retinal degeneration 32.5 PRPH2 RHO RLBP1 RP2 RPE65 RPGR
15 macular degeneration, age-related, 1 32.4 PRPH2 RHO RLBP1 RPE65
16 cone-rod dystrophy 2 32.2 CERKL PRPH2 RHO RPE65 RPGR RPGRIP1
17 usher syndrome, type iid 31.8 RHO RPGR
18 congenital stationary night blindness 31.8 RHO RPE65 RPGR
19 leber congenital amaurosis 31.7 IMPDH1 PRPH2 RHO RP2 RPE65 RPGR
20 rhyns syndrome 31.5 EYS PRPH2 RHO RP1 RPE65 RPGR
21 laurence-moon syndrome 31.1 RPGR RPGRIP1
22 stargardt disease 30.8 EYS PRPH2 RHO RPE65 RPGR
23 fundus dystrophy 29.9 CERKL EYS PRPH2 RGR RHO RLBP1
24 leber congenital amaurosis 9 29.8 RPE65 RPGRIP1
25 stargardt macular degeneration 29.6 PRPH2 RHO
26 retinitis pigmentosa 27.5 CERKL EYS FLVCR1 IMPDH1 KLHL7 PRPF3
27 retinal detachment 12.3
28 retinitis pigmentosa 3 12.3
29 retinitis pigmentosa 12 12.2
30 retinitis pigmentosa 27 12.2
31 central retinal vein occlusion 12.2
32 retinitis pigmentosa 11 12.2
33 retinitis pigmentosa 4 12.2
34 doyne honeycomb retinal dystrophy 12.2
35 retinitis pigmentosa 14 12.2
36 retinitis pigmentosa 19 12.2
37 retinitis pigmentosa 25 12.2
38 retinitis pigmentosa 17 12.2
39 retinitis pigmentosa 26 12.2
40 retinitis pigmentosa 28 12.2
41 retinitis pigmentosa 31 12.2
42 retinitis pigmentosa 33 12.2
43 central retinal artery occlusion 12.2
44 retinitis pigmentosa 23 12.2
45 retinitis pigmentosa 45 12.2
46 retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities 12.2
47 late-onset retinal degeneration 12.2
48 retinitis pigmentosa-deafness syndrome 12.2
49 cytomegalovirus retinitis 12.2
50 posterior column ataxia with retinitis pigmentosa 12.1

Graphical network of the top 20 diseases related to Retinitis:



Diseases related to Retinitis

Symptoms & Phenotypes for Retinitis

GenomeRNAi Phenotypes related to Retinitis according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased HPV16-GFP infection GR00350-A 8.92 FLVCR1 IMPDH1 RP2 RPE65

MGI Mouse Phenotypes related to Retinitis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 pigmentation MP:0001186 9.5 PRPF3 PRPH2 RHO RLBP1 RPE65 RPGR
2 vision/eye MP:0005391 9.4 CERKL PRPF3 PRPH2 RGR RHO RLBP1

Drugs & Therapeutics for Retinitis

Drugs for Retinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 239)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cidofovir Approved Phase 4,Phase 2,Phase 3,Phase 1 113852-37-2 60613
2
Ganciclovir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 82410-32-0 3454
3
Foscarnet Approved Phase 4,Phase 3,Phase 2,Phase 1 4428-95-9, 63585-09-1 3415
4
Probenecid Approved, Investigational Phase 4,Phase 2,Phase 1 57-66-9 4911
5
Phosphonoacetic Acid Experimental Phase 4,Phase 3,Phase 2,Phase 1 4408-78-0 546
6 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
7 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
9 Ganciclovir triphosphate Phase 4,Phase 3,Phase 2,Phase 1
10 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
11 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1
12 Reverse Transcriptase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
13 Renal Agents Phase 4,Phase 2,Phase 1
14
Valganciclovir Approved, Investigational Phase 3,Phase 2 175865-60-8 64147
15
Eplerenone Approved Phase 2, Phase 3 107724-20-9 443872 150310
16
Spironolactone Approved Phase 2, Phase 3,Phase 1 1952-01-7, 52-01-7 5833
17
Clindamycin Approved, Vet_approved Phase 3 18323-44-9 29029
18
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2 50-02-2 5743
19
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
20
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
21
Pyrimethamine Approved, Investigational, Vet_approved Phase 3 58-14-0 4993
22
Sulfadiazine Approved, Investigational, Vet_approved Phase 3 68-35-9 5215
23
Celecoxib Approved, Investigational Phase 3 169590-42-5 2662
24
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 1,Phase 2,Early Phase 1 59-30-3 6037
25
leucovorin Approved, Nutraceutical Phase 3,Phase 1,Phase 2 58-05-9 143 6006
26
Lutein Approved, Investigational, Nutraceutical Phase 3,Phase 1,Phase 2 127-40-2 6433159
27
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3,Phase 1 68-26-8, 11103-57-4 445354
28
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
29 Tocopherol Approved, Investigational, Nutraceutical Phase 3
30
Vitamin E Approved, Nutraceutical, Vet_approved Phase 3 59-02-9 14985
31
B-Carotene Approved, Nutraceutical Phase 2, Phase 3,Phase 1 7235-40-7 5280489
32 diuretics Phase 2, Phase 3,Phase 1
33 Diuretics, Potassium Sparing Phase 2, Phase 3,Phase 1
34 Hormone Antagonists Phase 2, Phase 3, Phase 1
35 Hormones Phase 2, Phase 3, Phase 1
36 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2, Phase 3, Phase 1
37 Mineralocorticoid Receptor Antagonists Phase 2, Phase 3,Phase 1
38 Mineralocorticoids Phase 2, Phase 3,Phase 1
39 Natriuretic Agents Phase 2, Phase 3,Phase 1
40 Anti-Bacterial Agents Phase 3,Phase 1,Phase 2
41 Antiemetics Phase 3,Phase 2
42 Anti-Inflammatory Agents Phase 3,Phase 2
43 Antimalarials Phase 3
44 Antineoplastic Agents, Hormonal Phase 3,Phase 2
45 Antiparasitic Agents Phase 3
46 Antiprotozoal Agents Phase 3
47 Autonomic Agents Phase 3,Phase 2,Phase 1
48 BB 1101 Phase 3,Phase 2
49 Clindamycin palmitate Phase 3
50 Clindamycin phosphate Phase 3

Interventional clinical trials:

(show top 50) (show all 234)

# Name Status NCT ID Phase Drugs
1 Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis Completed NCT00000894 Phase 4 Cidofovir;Probenecid;Ganciclovir
2 The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction Completed NCT00717080 Phase 4
3 A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) Completed NCT00002125 Phase 4 Foscarnet sodium
4 Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration Completed NCT01866397 Phase 4
5 Use of Cidofovir for Recurrent Respiratory Papillomatosis Completed NCT00205374 Phase 4 Cidofovir;Placebo
6 Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection Unknown status NCT00017784 Phase 3 Valganciclovir
7 A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy Unknown status NCT02215330 Phase 2, Phase 3 Eplerenone;Maltodextrin
8 To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis Unknown status NCT00372294 Phase 3 pyrimethamine-sulfadiazine + prednisolone;Clindamycin+Dexamethasone
9 Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A Completed NCT00346333 Phase 3 Lutein
10 Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed NCT00000142 Phase 2, Phase 3 Cidofovir
11 Randomized Trial for Retinitis Pigmentosa Completed NCT00000116 Phase 3 Vitamin A;Nutritional Supplement
12 A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS Completed NCT00000688 Phase 3 Ganciclovir
13 A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis Completed NCT00000698 Phase 3 Ganciclovir
14 Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis Completed NCT00002070 Phase 3 Sargramostim;Ganciclovir
15 Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) Completed NCT00000136 Phase 3 Foscarnet;Ganciclovir
16 Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) Completed NCT00000135 Phase 2, Phase 3 MSL-109
17 Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) Completed NCT00000143 Phase 3 Cidofovir intravenous
18 Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa Completed NCT00000114 Phase 3 Vitamin E;Vitamin A
19 Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) Completed NCT00000134 Phase 3 Ganciclovir;Foscarnet
20 Ganciclovir Implant Study for Cytomegalovirus Retinitis Completed NCT00000118 Phase 3
21 A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes Completed NCT00002377 Phase 3 Valganciclovir;Ganciclovir
22 Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT) Completed NCT00330018 Phase 3 Valganciclovir;Acyclovir
23 Ozurdex for Macular Edema Post Membrane Peeling Completed NCT01273727 Phase 2, Phase 3 Dexamethasone;dexamethasone
24 Laser and Medical Treatment of Diabetic Macular Edema Completed NCT00050479 Phase 3 Celecoxib (Celebrex)
25 The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil Recruiting NCT01680510 Phase 2, Phase 3
26 Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Recruiting NCT03013543 Phase 2, Phase 3 Setmelanotide
27 Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Not yet recruiting NCT03184584 Phase 2, Phase 3 PBI-4050
28 Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa Terminated NCT01786395 Phase 3 UF-021;Placebo
29 Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa Unknown status NCT01914913 Phase 1, Phase 2
30 A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) Unknown status NCT02110225 Phase 1, Phase 2 rhNGF 60 µg/ml eye drops solution;rhNGF 180 µg/ml eye drops solution;Placebo
31 Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome Unknown status NCT02739217 Phase 2 PBI-4050
32 Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa Completed NCT01560715 Phase 2
33 Trial of Oral Valproic Acid for Retinitis Pigmentosa Completed NCT01233609 Phase 2 Valproic Acid;Placebo
34 Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa Completed NCT02140164 Phase 1, Phase 2 Minocycline
35 A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa Completed NCT00447993 Phase 2 NT-501;NT-501
36 Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa Completed NCT02320812 Phase 1, Phase 2
37 Safety Study in Retinal Transplantation for Retinitis Pigmentosa. Completed NCT00345917 Phase 2
38 A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa Completed NCT00447980 Phase 2 NT-501;NT-501
39 CMV Retinitis Retreatment Trial Completed NCT00000766 Phase 2 Foscarnet sodium;Ganciclovir
40 Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema Completed NCT02609165 Phase 2 rhNGF 180 µg/ml eye drops solution;vehicle eye drops
41 Effects of Lutein in Retinitis Pigmentosa Completed NCT00029289 Phase 1, Phase 2 Lutein (10 or 30 mg/day) capsules
42 A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) Completed NCT00002156 Phase 2 Fomivirsen sodium;Ganciclovir
43 A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis Completed NCT00002169 Phase 2 Nelfinavir mesylate
44 DHA and X-Linked Retinitis Pigmentosa Completed NCT00100230 Phase 2 docosahexaenoic acid OR corn/soy oil placebo
45 A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure Completed NCT00000691 Phase 2 Foscarnet sodium
46 An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa Completed NCT00661479 Phase 1, Phase 2 400 µg Brimonidine Tartrate Implant;200 µg Brimonidine Tartrate Implant;100 µg Brimonidine Tartrate Implant
47 Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis Completed NCT00004794 Phase 2 cidofovir
48 The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes Completed NCT00002356 Phase 2 Fomivirsen sodium
49 The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Completed NCT00002437 Phase 2 Cidofovir;Probenecid
50 Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa Completed NCT01399515 Phase 2 Valproic Acid

Search NIH Clinical Center for Retinitis

Genetic Tests for Retinitis

Anatomical Context for Retinitis

MalaCards organs/tissues related to Retinitis:

38
Eye, Endothelial, Retina, Bone, Testes, T Cells, Brain

Publications for Retinitis

Articles related to Retinitis:

(show top 50) (show all 12300)
# Title Authors Year
1
Association between Optic Nerve Head Deformation and Retinal Microvasculature in High Myopia. ( 29421295 )
2018
2
Nonclinical Safety Evaluation of scAAV8-<i>RLBP1</i>for Treatment of<i>RLBP1</i>Retinitis Pigmentosa. ( 29359172 )
2018
3
Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease. ( 29380183 )
2018
4
Bilateral arterial occlusions masking retinitis in a HIV-positive male. ( 29380798 )
2018
5
Nonaccidental injury presenting as unilateral Retinal Detachment in two infants. ( 29410140 )
2018
6
Early quantitative profiling of differential retinal protein expression in lens-induced myopia in guinea pig using fluorescence difference two-dimensional gel electrophoresis. ( 29436656 )
2018
7
Central retinal vein occlusion in temporal arteritis: red sign or red herring? ( 29361164 )
2018
8
A novel mutation in<i>PRPF31</i>, causative of autosomal dominant retinitis pigmentosa, using the BGISEQ-500 sequencer. ( 29375987 )
2018
9
Spectral domain optical coherence tomography and fundus autofluorescence findings in cytomegalovirus retinitis in HIV-infected patients. ( 29445945 )
2018
10
Primary Cilium-Mediated Retinal Pigment Epithelium Maturation Is Disrupted in Ciliopathy Patient Cells. ( 29298421 )
2018
11
High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status. ( 29249380 )
2018
12
Chemical shift assignments of retinal degeneration 3 protein (RD3). ( 29327102 )
2018
13
Novel Animal Model of Crumbs-Dependent Progressive Retinal Degeneration That Targets Specific Cone Subtypes. ( 29368007 )
2018
14
Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome. ( 29435590 )
2018
15
Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment. ( 29228826 )
2018
16
Effects of Dexamethasone Implant on Multifocal Electroretinography in Central Retinal Vein Occlusion. ( 29403585 )
2018
17
Effects of molsidomine on retinal ischemia/reperfusion injury in rabbits. ( 29323543 )
2018
18
Renal histopathological findings of retinal vasculopathy with cerebral leukodystrophy. ( 29322432 )
2018
19
Treatment of cystoid macular edema in homozygous twins with glutathione synthetase deficiency and retinal dystrophy. ( 29395598 )
2018
20
A model to study complement involvement in experimental retinal degeneration. ( 29436895 )
2018
21
Retinal Avascularity and Neovascularization Associated With LAMA1 (laminin1) Mutation in Poretti-Boltshauser Syndrome. ( 29167897 )
2018
22
Improved retinal and visual function following panmacular subthreshold diode micropulse laser for retinitis pigmentosa. ( 29449615 )
2018
23
Xanthohumol Protects Morphology and Function in a Mouse Model of Retinal Degeneration. ( 29305606 )
2018
24
OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY EVALUATION OF COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM. ( 29370036 )
2018
25
Antagonistic regulation of trafficking to<i>Caenorhabditis elegans</i>sensory cilia by a<i>Retinal Degeneration 3</i>homolog and retromer. ( 29282322 )
2018
26
Branch retinal artery occlusion post-penetrating globe injury with intraocular foreign body. ( 29283146 )
2018
27
Optical Coherence Tomography-Based Angiography in Retinal Artery Occlusion in Children. ( 29393247 )
2018
28
YC-1 Inhibits VEGF and Inflammatory Mediators Expression on Experimental Central Retinal Vein Occlusion in Rhesus Monkey. ( 29364731 )
2018
29
Elevated serum IGF-1 level enhances retinal and choroidal thickness in untreated acromegaly patients. ( 29318448 )
2018
30
Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease. ( 29372250 )
2018
31
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment - reply to the letter to the editor. ( 29368041 )
2018
32
Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension. ( 29298687 )
2018
33
Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion. ( 29447089 )
2018
34
Analysis of the characteristics of optical coherence tomography angiography for retinal cavernous hemangioma: A case report. ( 29443780 )
2018
35
SOCS3 deficiency in myeloid cells promotes retinal degeneration and angiogenesis through arginase-1 up-regulation in experimental autoimmune uveoretinitis. ( 29452101 )
2018
36
Jules Gonin and the Nobel Prize: pioneer of retinal detachment surgery who almost received a Nobel Prize in medicine. ( 29372074 )
2018
37
Response of central serous chorioretinopathy evaluated by multimodal retinal imaging. ( 29303152 )
2018
38
Disorganization of Inner Retina and Outer Retinal Morphology in Diabetic Macular Edema. ( 29327033 )
2018
39
Pathogenesis of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) or 'idiopathic retinal arteriolar aneurysms (IRAA)' with macular star. ( 29447942 )
2018
40
P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model. ( 29207073 )
2018
41
Quantification of Macular Microvascular Changes in Patients With Retinitis Pigmentosa Using Optical Coherence Tomography Angiography. ( 29365150 )
2018
42
<i>GUCY2D</i> Cone-Rod Dystrophy-6 is a 'Phototransduction Disease' Triggered by Abnormal Calcium Feedback on Retinal Membrane Guanylyl Cyclase 1. ( 29440533 )
2018
43
Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study. ( 29399708 )
2018
44
Acute retinal detachment induced by the Valsalva manoeuvre in morning glory disc anomaly. ( 29374647 )
2018
45
Effect of oral Colchicine on Peripapillary retinal nerve fiber layer thickness in patients with familial Mediterranean fever. ( 29402238 )
2018
46
Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis. ( 29059086 )
2018
47
Concise Review: Human Induced Pluripotent Stem Cell Models of Retinitis Pigmentosa. ( 29345014 )
2018
48
Misdiagnosis of X-linked retinitis pigmentosa in a choroideremia patient with heavily pigmented fundi. ( 29377744 )
2018
49
An exudate detection method for diagnosis risk of diabetic macular edema in retinal images using feature-based and supervised classification. ( 29318442 )
2018
50
Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran ( 29373909 )
2018

Variations for Retinitis

Expression for Retinitis

Search GEO for disease gene expression data for Retinitis.

Pathways for Retinitis

Pathways related to Retinitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.69 RHO RLBP1 RPE65
2
Show member pathways
10.54 RHO RLBP1 RPE65
3 9.91 RGR RHO

GO Terms for Retinitis

Cellular components related to Retinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cilium GO:0005929 9.46 RP1 RP2 RPGR RPGRIP1
2 U4/U6 x U5 tri-snRNP complex GO:0046540 9.26 PRPF3 SNRNP200
3 photoreceptor inner segment GO:0001917 9.13 CERKL RHO RP1
4 photoreceptor outer segment GO:0001750 9.02 CERKL PRPH2 RHO RP1 RPGR

Biological processes related to Retinitis according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 response to stimulus GO:0050896 9.76 EYS RGR RHO RLBP1 RP1 RPE65
2 retinoid metabolic process GO:0001523 9.54 RHO RLBP1 RPE65
3 phototransduction GO:0007602 9.51 RGR RHO
4 response to light stimulus GO:0009416 9.49 RHO RPE65
5 detection of light stimulus involved in visual perception GO:0050908 9.48 EYS RPE65
6 protein-chromophore linkage GO:0018298 9.46 RGR RHO
7 retina morphogenesis in camera-type eye GO:0060042 9.43 RP1 RPE65
8 phototransduction, visible light GO:0007603 9.4 RHO RP1
9 retina development in camera-type eye GO:0060041 9.35 PRPH2 RHO RP1 RPE65 RPGRIP1
10 vitamin A metabolic process GO:0006776 9.32 RLBP1 RPE65
11 visual perception GO:0007601 9.32 EYS PRPH2 RGR RHO RLBP1 RP1
12 cellular response to light stimulus GO:0071482 9.26 RHO RP1

Molecular functions related to Retinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 photoreceptor activity GO:0009881 9.16 RGR RHO
2 G-protein coupled photoreceptor activity GO:0008020 8.96 RGR RHO
3 11-cis retinal binding GO:0005502 8.62 RHO RLBP1

Sources for Retinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....